ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.3724C>T (p.Arg1242Cys)

dbSNP: rs587779285
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000218524 SCV000276502 uncertain significance Hereditary cancer-predisposing syndrome 2021-08-02 criteria provided, single submitter clinical testing The p.R1242C variant (also known as c.3724C>T), located in coding exon 8 of the MSH6 gene, results from a C to T substitution at nucleotide position 3724. The arginine at codon 1242 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been identified in an individual diagnosed with diffuse gastric cancer (Henn J et al. Hered Cancer Clin Pract. 2019 Jan;17:5). This alteration was also detected on a 25-gene panel test in a woman who was diagnosed with breast cancer after age 50 (Tung N et al. Cancer. 2015 Jan;121:25-33). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV001243869 SCV001417055 uncertain significance Hereditary nonpolyposis colorectal neoplasms 2023-09-18 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1242 of the MSH6 protein (p.Arg1242Cys). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with MSH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 232375). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MSH6 protein function. This variant disrupts the p.Arg1242 amino acid residue in MSH6. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24763289, 28514183, 31204389). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV003322762 SCV004028079 uncertain significance not provided 2023-08-17 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25111426, 17531815, 21120944, 25186627, 30680046, 30982232, 31204389, 28514183, 24763289)
Baylor Genetics RCV003462494 SCV004195768 uncertain significance Endometrial carcinoma 2023-05-26 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV003997965 SCV004835120 uncertain significance Lynch syndrome 2023-03-23 criteria provided, single submitter clinical testing This missense variant replaces arginine with cysteine at codon 1242 of the MSH6 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with gastric cancer (PMID: 30680046), and in individuals affected with breast and/or ovarian cancer (PMID: 25186627, 30982232). This variant has been identified in 1/251188 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Different variants affecting the same codon, c.3725G>A (p.Arg1242His), c.3724C>A (p.Arg1242Ser), and c.3724C>G (p.Arg1242Gly), are considered to be disease-causing (ClinVar variation ID: 140866, 89449, 455280), suggesting that arginine at this position is important for the protein function. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.